UNICK FIX-A-FORM AND PRINTERS | ASTRAZENECA PHARMA | UNICK FIX-A-FORM AND PRINTERS/ ASTRAZENECA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 28.4 | 95.0 | 29.9% | View Chart |
P/BV | x | 1.2 | 22.6 | 5.2% | View Chart |
Dividend Yield | % | 0.0 | 0.3 | - |
UNICK FIX-A-FORM AND PRINTERS ASTRAZENECA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
ASTRAZENECA PHARMA Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ ASTRAZENECA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 3,620 | 1.6% | |
Low | Rs | 32 | 2,438 | 1.3% | |
Sales per share (Unadj.) | Rs | 120.5 | 401.2 | 30.0% | |
Earnings per share (Unadj.) | Rs | 4.1 | 39.7 | 10.3% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 46.2 | 24.3% | |
Dividends per share (Unadj.) | Rs | 0 | 16.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.5 | 0.0% | |
Book value per share (Unadj.) | Rs | 53.9 | 234.4 | 23.0% | |
Shares outstanding (eoy) | m | 5.49 | 25.00 | 22.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 7.5 | 5.0% | |
Avg P/E ratio | x | 11.1 | 76.3 | 14.5% | |
P/CF ratio (eoy) | x | 4.0 | 65.5 | 6.2% | |
Price / Book Value ratio | x | 0.8 | 12.9 | 6.5% | |
Dividend payout | % | 0 | 40.3 | 0.0% | |
Avg Mkt Cap | Rs m | 248 | 75,718 | 0.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 2,591 | 3.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 10,030 | 6.6% | |
Other income | Rs m | 5 | 261 | 2.0% | |
Total revenues | Rs m | 667 | 10,291 | 6.5% | |
Gross profit | Rs m | 88 | 1,249 | 7.0% | |
Depreciation | Rs m | 39 | 163 | 24.1% | |
Interest | Rs m | 24 | 6 | 378.1% | |
Profit before tax | Rs m | 30 | 1,341 | 2.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 348 | 2.1% | |
Profit after tax | Rs m | 22 | 993 | 2.3% | |
Gross profit margin | % | 13.3 | 12.5 | 106.5% | |
Effective tax rate | % | 25.0 | 26.0 | 96.3% | |
Net profit margin | % | 3.4 | 9.9 | 34.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 9,359 | 3.2% | |
Current liabilities | Rs m | 287 | 4,844 | 5.9% | |
Net working cap to sales | % | 2.1 | 45.0 | 4.7% | |
Current ratio | x | 1.0 | 1.9 | 54.3% | |
Inventory Days | Days | 4 | 49 | 7.8% | |
Debtors Days | Days | 72,349,839 | 39 | 184,902,759.9% | |
Net fixed assets | Rs m | 402 | 2,061 | 19.5% | |
Share capital | Rs m | 55 | 50 | 109.7% | |
"Free" reserves | Rs m | 241 | 5,811 | 4.1% | |
Net worth | Rs m | 296 | 5,861 | 5.0% | |
Long term debt | Rs m | 89 | 0 | - | |
Total assets | Rs m | 705 | 11,421 | 6.2% | |
Interest coverage | x | 2.3 | 213.9 | 1.1% | |
Debt to equity ratio | x | 0.3 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0.9 | 106.8% | |
Return on assets | % | 6.6 | 8.7 | 74.9% | |
Return on equity | % | 7.6 | 16.9 | 44.7% | |
Return on capital | % | 14.0 | 23.0 | 60.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 37.4 | 0.0% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | 3,747 | 0.0% | |
Fx inflow | Rs m | 0 | 612 | 0.0% | |
Fx outflow | Rs m | 0 | 3,747 | 0.0% | |
Net fx | Rs m | 0 | -3,135 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 583 | 7.5% | |
From Investments | Rs m | -27 | 181 | -14.9% | |
From Financial Activity | Rs m | -16 | -245 | 6.7% | |
Net Cashflow | Rs m | 0 | 519 | 0.1% |
Indian Promoters | % | 71.6 | 75.0 | 95.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 6.5 | 6.9% | |
FIIs | % | 0.0 | 2.7 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 25.0 | 113.7% | |
Shareholders | 1,622 | 29,418 | 5.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | ASTRAZENECA PHARMA | S&P BSE TECK |
---|---|---|---|
1-Day | 0.00% | 0.68% | 0.02% |
1-Month | 10.53% | 1.96% | -2.08% |
1-Year | 46.51% | 58.84% | 23.56% |
3-Year CAGR | 28.85% | 11.30% | 10.04% |
5-Year CAGR | 23.20% | 19.68% | 15.56% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the ASTRAZENECA PHARMA share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of ASTRAZENECA PHARMA.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of ASTRAZENECA PHARMA.
For a sector overview, read our media sector report.
After opening the day weak, Indian share markets pared losses as the session progressed and ended the day higher.